American Well Corporation reports developments for Amwell, a SaaS-based software platform for technology-enabled healthcare used by payers and health systems. Company updates center on quarterly and annual operating results, business reviews, investor conference participation, and equity-compensation actions such as inducement-plan grants.
The Amwell platform combines software and services that support virtual care programs across the care continuum, including virtual primary care, urgent care, clinical partner programs, scheduling, provider workflows, prescribing, and treatment-guideline reference tools. News about AMWL commonly connects these platform capabilities with payer and health system relationships, partner clinical programs, and management commentary on technology-enabled care delivery.
Amwell, a leader in telehealth (NYSE: AMWL), introduced its next-generation Converge telehealth platform at its annual Client Forum. This platform aims to enhance connectivity among healthcare providers, offering a unified care experience through flexibility and scalability. It incorporates features from notable partners like Google Cloud and TytoCare, ensuring improved patient engagement and diagnosis. The Converge platform's open architecture allows clients to customize their capabilities while ensuring a seamless integration with existing healthcare systems, ultimately facilitating better health outcomes.
Amwell, a leader in telehealth (NYSE: AMWL), will announce its first quarter operating results for the period ending March 31, 2021, on May 12, 2021. Following the release, the management team will hold a conference call and webcast at 5:00 p.m. ET to discuss the results and provide a business update. Investors can access the webcast via the Company’s website or listen via phone by calling (833) 979-2840 (U.S.) or (236) 384-2051 (International), using conference ID 4793448. A replay will be available for 90 days post-call.
Amwell®, a leader in telehealth, reported strong fourth-quarter and full-year financial results for 2020. The total active providers surged to ~72,000 from ~7,000 the previous year, and total visits reached ~1.6 million, up from 355,000. Total revenue rose to $60.4 million, compared to $45.0 million, while subscription and visit revenues increased significantly. Despite these gains, the net loss widened to $50.6 million from $22.7 million. For 2021, Amwell anticipates revenue between $260 million and $270 million and AMG visits of 1.5 to 1.7 million.
Amwell (NYSE: AMWL), a leader in telehealth, has joined the Moving Health Home coalition to advance home-based care delivery. This initiative aims to unite stakeholders to enhance home care sustainability, particularly for seniors with chronic conditions. Notably, home-based care can significantly reduce healthcare costs and improve patient outcomes. Amwell's commitment emphasizes the need for a hybrid care model following lessons learned during the pandemic. The company aims to create a healthcare system that enhances quality of life for patients.
Amwell (NYSE: AMWL), a leader in telehealth, will report its fourth quarter and full year operating results for 2020 on March 24, 2021. A live conference call and webcast will follow at 5:00 p.m. ET to discuss these results and provide a business update. Interested parties can access the webcast via the investors.amwell.com website or call (833) 979-2840 for the live call. The company supports over 2,000 hospitals and 55 health plans, covering 80 million lives with telehealth solutions.
Amwell (NYSE: AMWL) has announced the launch of the Hospital TV 100, a new Carepoint device aimed at enhancing telehealth connectivity in hospitals. This device allows hospitals to use existing televisions as telehealth endpoints, enabling care teams to monitor patients remotely without additional infrastructure costs. With over 1,200 installations across 50 locations at Intermountain Healthcare, this innovation addresses strained resources amid the COVID-19 pandemic. Amwell continues to expand its telehealth services, underscoring its commitment to improving healthcare accessibility.
Amwell (NYSE: AMWL) announced a public offering of 11,280,647 shares of its Class A common stock at a price of $27.50 per share, led by certain stockholders. The offering includes a 30-day option for underwriters to purchase an additional 1,692,097 shares. Notably, Amwell will not receive any proceeds from this offering. The transaction is expected to close on January 20, 2021, subject to customary conditions. The offering is led by Morgan Stanley, Goldman Sachs, Piper Sandler, and UBS Investment Bank, with the registration statement effective since January 14, 2021.
Amwell (NYSE: AMWL) announced the commencement of its public offering roadshow, involving the sale of 11,280,647 shares of Class A common stock by certain Selling Stockholders. An additional 1,692,097 shares may be purchased by underwriters. Amwell will not receive proceeds from this offering, which is led by Morgan Stanley and Goldman Sachs. A registration statement has been filed with the SEC, pending effectiveness. This move highlights Amwell's focus on expanding its telehealth services, which already connect over 80 million lives.
Amwell (NYSE: AMWL) has announced the launch of Amwell Psychiatric Care, a new telepsychiatry solution aimed at hospitals and health systems to address the escalating demand for behavioral healthcare in the U.S. This service offers 24/7 access to board-certified psychiatrists and seeks to improve patient throughput in emergency departments. Asana Integrated Medical Group, part of Amwell since 2019, has received The Joint Commission's Gold Seal for Behavioral Healthcare Accreditation, reinforcing Amwell's commitment to quality care in the mental health sector.
Amwell (NYSE: AMWL) announced new leadership appointments, with Egbert van Acht as Executive Vice Chairman and Frank McGillin as CEO. This joint venture with Cleveland Clinic aims to enhance digital health services, especially in telemedicine, which has surged during the COVID-19 pandemic. The company focuses on offering high-acuity care via its MyConsult platform, supporting over 2,000 conditions. Both leaders bring extensive experience from global organizations, highlighting the company's strategy to leverage Cleveland Clinic's expertise and Amwell's technology for improved patient care.